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Recent discoveries demonstrate a critical role for circadian rhythms and sleep in immune system 
homeostasis. Both innate and adaptive immune responses — ranging from leukocyte mobilization, 
trafficking, and chemotaxis to cytokine release and T cell differentiation —are mediated in a 
time of day–dependent manner. The National Institutes of Health (NIH) recently sponsored 
an interdisciplinary workshop, “Sleep Insufficiency, Circadian Misalignment, and the Immune 
Response,” to highlight new research linking sleep and circadian biology to immune function and 
to identify areas of high translational potential. This Review summarizes topics discussed and 
highlights immediate opportunities for delineating clinically relevant connections among biological 
rhythms, sleep, and immune regulation.
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Introduction
Circadian rhythms are daily variations in behavior and biological activity that stem from an intrinsic ability 
of  organisms to align themselves with the environmental 24-hour light/dark cycle. These rhythms origi-
nate from an internal biological clock that drives many aspects of  human physiology, including the sleep-
wake cycle and daily variations in blood pressure, body temperature, and cortisol (1). A growing body 
of  epidemiological evidence demonstrates an association between altering circadian timing through shift 
work or frequent time zone travel and increased rates of  cardiovascular disorders, metabolic syndrome, and 
cancer (2–4). Clinical aspects of  disease such as pain perception, asthma exacerbations, and myocardial 
infarctions are more common at certain times of  day or night (5, 6). The discovery of  the genetic basis for 
the circadian clock in the 1980s and 1990s has ushered in a new era in which long-appreciated circadian 
rhythms in physiology and clinical medicine are being reframed in terms of  gene expression, metabolism, 
signal transduction, and cellular physiology (7). The translation of  circadian discovery into strategies to 
improve the prevention and management of  disease promises to be transformative, but at present, funda-
mental research is outpacing clinical application (Figure 1A). Much will depend on research identifying 
the critical mechanisms and targets to which circadian rhythm–based therapeutic strategies can be applied. 
An emerging example of  exciting circadian discovery with potential clinical relevance is the intersection 
between circadian function and immune regulation (Figure 1B).
The NIH recently sponsored a workshop entitled “Sleep Insufficiency, Circadian Misalignment, and 
the Immune Response” (May 16–17, 2019, Rockville, Maryland, USA). Its aim was to highlight basic 
and clinical advances linking sleep and circadian biology to immune dysfunction, thereby stimulating the 
application of  circadian biology to translational medicine. The Workshop was cosponsored by four NIH 
institutes — the National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), 
National Institute of  Allergy and Infectious Diseases (NIAID), and National Institute on Alcohol Abuse 
and Alcoholism (NIAAA) — reflecting a broad interest and recognizing that circadian and sleep-based 
research cuts across traditional academic disciplines. Here, we report the perspective of  the Workshop 
participants on circadian biology, sleep, and immunity, and review emerging literature that links circadian 
rhythms and sleep to specific immune functions. Finally, we highlight future research opportunities as well 
as challenges that need to be overcome in order to implement chronotherapy in clinical settings.
Introduction to the molecular circadian clock
Circadian rhythms evolved as organisms were selected for their preparedness for the environmental shifts brought 
about by the solar day (8). The molecular model for circadian rhythm generation arose from genetic screens 
designed to find mutations that disturb the sleep-wake cycle in model organisms (7). In both flies and mammals, 
the key constituents of the molecular circadian clock are either transcription factors or transcription factor regu-
lators (i.e., “clock genes”; Figure 2). At the core of the clock is a heterodimer composed of the proteins BMAL1 
and CLOCK (9). This complex stimulates transcription by altering the chromatin landscape around genes con-
taining E-box motifs in their promoters (10). Among the downstream effectors of BMAL1/CLOCK are fellow 
clock gene products Per1–3, Cry1/2, NR1D1/2 (also known as REV-ERBα/β, and RORα–γ, whose products 
either negatively or positively regulate the core complex (9). Thus, the expression of clock genes oscillates with 
roughly a 24-hour periodicity, thereby biochemically representing the solar day. Other downstream effectors of  
the molecular clock include master transcription factors, such as the PAR domain basic leucine zipper transcrip-
tion factor family (DBP, TEF, and HLF) (11), nuclear factor IL-3–regulated (NFIL3, also known as E4BP4) 
(12), and the PPAR family (11, 13). Through these clock-controlled genes (CCGs) as well as others, the molec-
ular clock imparts a circadian pattern on gene expression, and by extension protein and metabolite abundance. 
Molecular clocks operate in almost all nucleated cells throughout the body, thereby allowing cells to factor time-
of-day information into the control of metabolism and other key pathways (14).
The molecular clock contains some special features that are important for its role in regulating the phys-
iology of  higher organisms. First, clock proteins and clock genes are subject to numerous forms of  biochem-
ical regulation, including acetylation, methylation, phosphorylation, ubiquitination, and sumoylation (15). 
Combined with signal transduction through accessory pathways, these modifications impact clock protein 
levels and activity, thereby allowing ambient biochemical cues, such as temperature, nutrient status, hormone 
levels, and innervation, to synchronize internal cellular time with the external world (16). This phenomenon 
is known as entrainment and serves an additional crucial role in creating temporal coherence within organs 
by synchronizing parenchymal cells with one another. To harmonize the various biochemical entrainment 
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cues, mammals require a “master circadian pacemaker” located in the suprachiasmatic nucleus (SCN) of  
the hypothalamus. The SCN receives light information from the retina and then projects to other CNS areas 
that regulate arousal, autonomic tone, temperature, and hormone secretion (16). Of all the entrainment cues, 
light has the largest impact on rest-activity rhythms, and the clocks within SCN neurons are selectively sensi-
tive to light for entrainment. However, because SCN clocks synchronize to changing light cycles faster than 
peripheral clocks, and because mistimed feeding or other biochemical cues can compete with SCN pacing in 
the periphery (17), it is possible to induce a state of  internal desynchronization. This desynchronization is 
thought to explain the sequelae of  jet lag and night-shift work (18–20). A second key feature of  the molecular 
clock is that its regulatory influence extends from the microscopic to the macroscopic biological scale. For 
example, mutations that alter the periodicity of  Per and Cry expression provoke analogous changes to the 
periodicity of  sleep timing and quality (21–23). A final feature is programmability. While the anatomy of  
the molecular clock is largely uniform across tissues, the circadian transcriptomes it generates (i.e., the set 
of  CCGs exhibiting rhythmic expression) are highly tissue specific and overlap by only about 10% between 
organs (24). The remarkable organ specificity of  circadian transcriptomes is thought to be a product of  cell 
type–specific transcription factors and tissue-selective patterns of  chromatin accessibility (25, 26). Collective-
ly, the cardinal molecular clock features of  entrainment, programmability, and the ability to impact function 
at all biological scales enable tissues to harness time-of-day information in the service of  their unique physi-
ologic contributions. They also makes it possible for the clock to organize diverse networks of  cells around a 
common goal, for example, a coordinated immune response.
Clocks and immunity
The current focus on circadian control of  immune function was presaged by the observations — first pub-
lished more than 50 years ago — that circulating lymphocyte counts oscillate on a daily basis in healthy 
humans (27) and that the susceptibility to endotoxin depends on the time of  day it is administered in 
rodents (28). More recent work highlights epidemiological associations between night-shift work (i.e., 
activity and sleep patterns in opposition to the normal day-night pattern) and elevated levels of  systemic 
inflammatory markers (29, 30). Significantly, all lymphoid organs and immune cell types tested to date 
harbor functional clocks (31, 32). Studies using genetic experimental approaches in human cells and mice 
suggest a connection between clocks and at least three fundamental immunologic activities.
The best-documented connection between clocks and immune function is the regulation of  proinflam-
matory cytokine secretion. Cytokines are well-known mediators of  host responses to infection, trauma, and 
immune responses. In endotoxin-stimulated macrophages, the magnitude of  TNF-α secretion was found 
to vary in a circadian fashion based on the time of  endotoxin challenge (31). The current paradigm for 
Figure 1. Citations in chronotherapy and circadian research are on the rise. (A) Number of 1990–2018 publications found with PubMed searches for “cir-
cadian” and “chronotherapy.” (B) Number of 1990–2018 publications found with PubMed searches for “sleep and immunity,” “circadian and immunity,” and 
“chronotherapy and immunity.” Chronotherapy is classically defined as the use of circadian information to maximize the therapeutic index of a medical 
intervention or to limit the amount of drug needed to achieve a clinical end point by giving it at the optimal time of day. An emerging use of the term is for 
the direct targeting of clock gene function to achieve a clinical end point, such as tumor killing (148). Illustrated by Rachel Davidowitz.
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explaining how the clock imparts rhythms to cytokine production involves the ability of  clock proteins to 
directly transactivate or repress gene expression of  key cytokines and chemokines, including CCL2, TNF, 
IL-6, and CXCL5 (reviewed in ref. 33). This paradigm also extends to CCGs. For example, in LPS-stimu-
lated macrophages, the clock-controlled transcription factors NFIL3 and DBP impart a circadian rhythm 
to IL-12(p40) secretion by alternating their binding to the Il12 promoter throughout the day (34). Thus, 
disruption of  molecular clock function through light-cycle desynchronization or deletion of  Bmal1 or Rever-
ba locks macrophages into a “time of  day” wherein inflammatory cytokine secretion is maximized (35, 
36). This hypersecretory phenotype is not limited to immune cells but extends to epithelial cells, which are 
responsible for initial leukocyte recruitment after infectious and sterile insults (36–38). Interestingly, inflam-
mation appears to feed back on the integrity of  the molecular clock. For example, Clock, REV-ERBα, 
and BMAL1 protein levels decline rapidly in cells after endotoxin treatment, which is predicted to disrupt 
clock function (39–41). Conversely, herpes virus infection stimulates Bmal1 promoter activity, leading to 
a corresponding depression in Cry1 and a disruption in the feedback relationships that underlie the clock 
(42). Indeed, disruption of  clock gene expression appears to be a common outcome of  acute infection and 
leads to novel rhythms of  gene expression characterized by prominent cycling of  proinflammatory genes 
(37, 43). Some suggest that the circadian clock is itself  a kind of  innate immune sensor that when disabled 
by infection automatically shifts cells to a proinflammatory state. However, during chronic inflammation 
or stressors such as shift work, disrupted clocks have been shown to increase the morbidity in response to 
infection or sterile insult through excessive inflammation (44–49).
Trafficking of  myeloid and lymphocyte subsets in healthy mice and humans is another circadian-reg-
ulated immune activity (50–52). Leukocyte trafficking represents the summation of  several discrete, indi-
vidually rhythmic processes (Figure 3), including cell egress from bone marrow (53, 54), leukocyte homing 
from the bloodstream to the interstitial space of  organs (51, 55), and removal of  leukocytes from organs 
through phagocytosis or via transit to regional lymph nodes (56, 57). Regardless of  cell type, mechanisms 
of  rhythmic trafficking involve coordinated clock function within the leukocyte and within endothelial cells 
lining the vessels of  peripheral organs. Together, these clocks align the expression of  receptor-ligand pairs 
critical for chemoattraction and adhesion to the endothelial surface, thereby facilitating leukocyte recruit-
Figure 2. Circadian regulation in mammals. Schematic depicting the currently accepted hierarchal model for circadian rhythm generation. Light infor-
mation is conveyed by the optic nerve to the SCN, a region of the ventral hypothalamus. There, light entrains clocks within SCN neurons, and this is 
ultimately converted by the CNS into pulsatile chemical and neurological cues, which entrain cell-autonomous circadian clocks residing in peripheral cells. 
These peripheral clocks impart circadian patterns on gene expression and overall cellular physiology. For simplicity, only the core molecular clock circuitry 
is depicted, with positive regulatory proteins labeled green and negative regulators labeled red. However, there are many accessory proteins and metabolic 
pathways that can adjust the periodicity and phase of the clock but are not central to rhythm generation (for example, casein kinase 1δ/ε [ref. 23], AMPK 
[ref. 149], mTOR [ref. 150], p53 [ref. 151], and SIRT1 [ref. 152]). There are additional molecular clock constituents (not depicted) that in the basal state 
appear to have more prominent roles in CNS clocks than clocks in peripheral cells. For example, NPAS2 (a functional homolog of CLOCK) and DEC1/2 pro-
vide additional negative feedback to BMAL1/CLOCK (16, 153). Yellow boxes represent E-boxes or ROR-responsive elements (RREs), which are the promoter 
motifs recognized by BMAL1/CLOCK or REV-ERB/ROR proteins, respectively. Clock genes and clock-controlled genes (CGs) are represented by green and 
purple arrows, respectively. Illustrated by Rachel Davidowitz.
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ment (51, 55). Additional levels of  control, including adrenergic tone and leukocyte ROS, appear to play a 
role in setting the phase of  leukocyte trafficking rhythms (51, 52, 58). Interestingly, the critical ligand-recep-
tor interactions needed for leukocyte homing appear to vary depending on the cell type and the destination 
organ (55). Altogether, the complexity of  leukocyte trafficking makes clear the importance of  the clock in 
optimizing this critical immune activity.
A third connection between clocks, clock genes, and immune processes is among the least studied: 
differentiation and maturation of  clinically important leukocyte subsets. For example, the canonical clock 
gene Rora is required for the differentiation of  type 2 innate lymphoid cells (ILC2s), which play a role in 
type II inflammation, allergy, and defense against parasites (59). A splice variant of  the clock gene Rorg 
(Rorgt) is critical for the development of  type 3 innate lymphoid cells (ILC3s), lymphoid tissue induc-
er (LTi) cells, and the CD4+ T helper cell subset Th17 cells (60–62). Rora is also important for the full 
development of  Th17 cells (63). ILC3s and Th17 cells are characterized by secretion of  IL-17, and both 
are implicated in autoimmune diseases. Disruption of  molecular clock function leads to aberrant Th17 
cell development and renders mice more susceptible to pathology in models of  autoimmunity, including 
experimental autoimmune encephalomyelitis (EAE), a mouse multiple sclerosis model, and colitis (64, 65). 
Interestingly, Rorgt mRNA expression is blocked by melatonin, a hormone with pleiotropic immunomod-
ulatory activity that is secreted in a circadian fashion by the pineal gland (66, 67). Finally, circadian clocks 
were recently found to regulate neutrophil maturation (68), which is remarkable given the short life span 
(only 1–2 days) of  these crucial effector cells. As neutrophils age, they undergo cytoskeletal and cell-ad-
hesive changes that enhance their migration into the interstitial spaces of  organs according to a circadian 
rhythm (53, 68). These changes are mediated by Bmal1, and loss of  this clock gene blocks their efficient 
homing to organs (68). The result is that initial innate responses against invading organisms are weakened 
in Bmal1-deficient mice, thereby increasing disease severity (68). Clock control of  neutrophil maturation 
has an additional homeostatic function, as trafficking of  aged neutrophils into the bone marrow suppresses 
the hematopoietic niches that control the egress of  leukocytes in the first place (53). In doing so, rhythmic 
neutrophil homing completes a feedback loop that may help to make circadian trafficking patterns for all 
hematopoietic types self-sustaining.
Altogether, it is increasingly clear that circadian gating is part of  the core programing of  the immune 
system, and thus, alteration of  this regimen is likely to have widespread ramifications for disease pathogen-
esis. Current evidence draws a direct mechanistic line between the biochemistry of  a clock protein, such as 
BMAL1, and a discrete immune parameter, like the production of  the neutrophil chemoattractant CXCL5 
during lung injury (36). Alternatively, the clock may impact immunity by regulating sleep.
Sleep and immunity
Sleep is a basic behavior common to almost all organisms and is defined by a period of  relative unrespon-
siveness to outside stimuli. In humans, sleep can be subdivided into an orderly progression of  neurolog-
ical stages based on EEG patterns that repeat roughly every 90 minutes (69). There is no consensus on 
what defines ideal sleep, but total sleep deprivation in rodents is fatal (70). It is still not fully understood 
why denying rodents sleep is deadly; however, studies have shown that chronically sleep-deprived animals 
exhibit splenic atrophy and polymicrobial bacteremia, suggesting that immune dysfunction may be part of  
the dying process (70, 71). In a similar vein, short habitual sleep (<6 hours per night) is statistically asso-
ciated in humans with reduced life span, increased vulnerability to viral infection, and reduced antibody 
titers after vaccination (72–74). Short-term sleep deprivation prior to vaccination appears to negatively 
impact antibody titers after influenza vaccination and, at least in rodents, reduces influenza vaccine efficacy 
(75–77). Just as sleep impacts immune functions, it appears that certain peripheral immune populations 
may affect sleep. For example, chemical or genetic ablation of  macrophages affects the architecture of  
rebound sleep in sleep-deprived mice (78, 79). Altogether, sleep is connected to an organism’s resilience 
against infection, and considerable work has been done in humans and animal models to examine how 
sleep deprivation impacts specific immune parameters (80).
The relationship between circadian rhythms and sleep is complex and likely bidirectional. In humans, the 
paradigm for sleep timing is a “two-process” model (processes C and S) in which CNS circadian clocks play 
a major role. Clocks generate daily oscillations in neurological arousal (process C), which promotes wakeful-
ness and opposes drowsiness that accumulates through sleep debt (process S) (81). Work in Bmal1-deficient 
model organisms suggests that clocks may have an additional role in mediating normal sleep architecture (82–
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Figure 3. Multilayered circadian control of leukocyte trafficking. Schematic depiction of the circadian regulation of specific leukocyte trafficking steps 
(55–57, 68). These include the egress of leukocytes from the bone marrow; adhesion of circulating leukocytes to endothelial cells in the capillary beds of 
end organs; and removal of leukocytes from the parenchyma of organs by phagocytosis or by migration to area lymph nodes. Proteins generally import-
ant for rhythmic leukocyte trafficking at specific steps in the process are depicted in red. For a comprehensive treatment of cell-specific determinants of 
leukocyte trafficking rhythms, see Pick et al. (154). Lymph/Mac, lymphocyte/macrophage. Illustrated by Rachel Davidowitz.
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84). While clocks gate sleep, it is also true that short-term sleep disruption can affect circadian regulation in 
peripheral tissues such as blood and lung, by either damping the rhythms in CCG expression or altering their 
phase (85, 86). Thus, while circadian rhythms and sleep are biologically different phenomena and can be ana-
lyzed in isolation using “forced synchronization” protocols in humans (87), it is difficult to perturb one with-
out affecting the other under naturalistic conditions. For physicians, the conflation of  circadian rhythms and 
sleep during disease dates to Greek antiquity. The writings of  Arataeus of  Cappadocia on asthma posed the 
question of  whether asthma exacerbations are more frequent at night because of  the time of  day or because 
patients are typically asleep at night (88). Some pathogens even corrupt the circadian-mediated sleep/wake 
cycle to promote disease. For example, Trypanosoma brucei (which causes African sleeping sickness) alters 
sleep patterns in afflicted subjects by shortening the periodicity of  the molecular circadian clock (89).
Given the interconnectedness of  sleep and circadian rhythms, it is understandable that the immune 
activities affected by insufficient sleep overlap with those altered by circadian disruption. Experimentally 
induced sleep deprivation and short habitual sleep increase proinflammatory cytokine secretion, particu-
larly in males (90, 91). Numbers of  circulating neutrophils, NK cells, monocytes, and B cells are increased 
by prolonged wakefulness and decreased by recovery sleep, suggesting a role for sleep in regulating leuko-
cyte trafficking (80, 92). Recent work in mice found that sleep fragmentation increases the production of  
inflammatory monocytes by the bone marrow and leads to atherosclerosis, an inflammatory pathology 
also induced by Bmal1 deficiency (93, 94). Finally, inadequate sleep seems to impair immune effector cell 
functions such as NK cell activity, at least in some experimental scenarios (80, 95).
Circadian rhythms and sleep are increasingly seen as important for immune system homeostasis. Dis-
ruption of  either process can engender a state of  inflammation and functional immunocompromise, ren-
dering organisms more vulnerable to disease. Historically, circadian biology, sleep, and immunology have 
occupied separate branches of  investigation. Consequently, there has been little interdisciplinary research 
on these topics. The key point is that circadian rhythm and sleep disruption happen concurrently every 
day through the widespread experiences of  shift work, nighttime light exposure, and social jet lag, which 
is caused by discontinuity between natural sleep-wake schedules and the variations in the social demands 
of  weekdays versus weekends. Thus, the interface between circadian rhythms, sleep, and immune function 
potentially has a wide range of  implications for public health and medicine.
Workshop-identified opportunities
The goal of  the NIH Workshop was to highlight recent basic and clinical research advances in sleep and 
circadian biology linking immune dysfunction to pathobiology, and to foster interdisciplinary conversa-
tions that could point toward future research objectives. Following 2 days of  presentations and discussions 
covering a wide range of  disease-based research, the participants developed recommendations on the most 
timely and compelling questions in this area. The participants also discussed various challenges for circadi-
an-immune and sleep-immune discovery research to be translated and implemented more effectively.
Adaptive immune response. The highest-priority knowledge gap identified by Workshop participants was 
the need to better understand the role of  circadian rhythms and sleep in adaptive immune responses. While 
there has been an intense focus on how clocks regulate innate immunity, research into the mechanisms 
connecting circadian and sleep disruption to adaptive immune functions remains sparse. This is partly due 
to early skepticism that something as short as a 24-hour clock could be relevant to antigen-specific B and T 
cell responses, which form over days to weeks. Results from prior experiments in mice with T cell–specific 
Bmal1 deletion were interpreted to mean that circadian clocks have little influence over adaptive immune 
activities (96). However, some of  these earlier experiments did not factor time of  day into the experimental 
design, and subsequent studies that controlled for this variable did report circadian effects in outcomes such 
as autoimmune pathology (56, 65). Moreover, T cell proliferation in response to antigen displays a circadi-
an rhythm in mice that is clock dependent (97). In other research, time of  day and sleep quantity were both 
shown to impact markers of  vaccine efficacy in humans and rodents (44, 74, 75, 97–99). Clocks may also 
affect adaptive immunity via control of  immune checkpoints, as disruption of  circadian rhythms in rodents 
appears to exacerbate bacterial peritonitis in part by increasing programmed cell death ligand 1 (PD-L1) 
expression on macrophages, which represses T cell activities (100). With this background, Workshop par-
ticipants identified a critical need to elucidate how circadian clocks mediate various aspects of  specific 
immunity. The potential clinical ramifications of  such research are very broad, including, but not limited 
to, the treatment of  autoimmunity (101), long-term preservation of  organ function in transplanted organs 
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such as the lung (102, 103), cancer immunotherapy (104–106), establishment of  allergic tolerance (107), 
“immune paralysis” that accompanies severe sepsis (100, 108), and even age-related changes in immune 
function (109, 110). A specific opportunity with high potential impact for public health is to achieve a better 
understanding of  how the timing of  immunization might influence the molecular and cellular processes 
underlying the establishment of  protective immunity. Such research could find application in improving 
existing immunization programs in the elderly and, importantly, in targeting diseases deemed to be difficult 
targets for vaccination, such as malaria (111–114).
Neuroinflammatory mechanisms. Examination of  neuroinflammatory mechanisms as a link by which 
circadian rhythms and sleep affect immunity was identified as another topic of  interest. It is increasingly 
appreciated that the nervous system and immune system share common mediators. For example, Th2 cyto-
kines, such as IL-4 and IL-13, figure prominently in the pathogenesis of  allergy and asthma but also serve 
as neurotransmitters within the peripheral nervous system, where they mediate itch (115, 116). Acetylcho-
line is a classic neurotransmitter of  the CNS and the autonomic nervous system but is also secreted by a 
subpopulation of  peripheral T cells (117, 118). Importantly, chronic itch has a strong nocturnal predom-
inance, and autonomic tone has a prominent circadian rhythm (51, 119). Moreover, clock gene deletion 
appears to exacerbate neurodegenerative disease in experimental models in part by inducing inflammatory 
responses in astrocytes (120, 121). Conversely, neurodegenerative diseases are accompanied by coincident 
disturbances in sleep and circadian activity patterns, implying a bidirectional relationship (122). Exploring 
potential circadian and sleep influences on neuroimmune pathways inside and outside the CNS could 
translate into new therapeutic approaches for a wide variety of  human diseases. One opportunity cited by 
Workshop participants was to better understand how circadian rhythms in autonomic tone contribute to 
neuroimmune reflexes, such as those that influence sepsis outcomes (123, 124). Results of  such research 
could find application in the treatment of  critical illnesses such as sepsis and pneumonia potentially by 
targeting the molecular clock and its downstream effectors, or by optimally timing interventions that target 
the inflammatory reflex. Another potential application is targeting the clock to reduce neuroinflammation 
that contributes to Alzheimer’s disease and other neurodegenerative disorders (120–122).
Microbiome and immunity. A third high-impact opportunity identified by Workshop participants is to better 
understand interrelationships among circadian rhythms, the microbiome, and immunity. The microbiome 
— made up of  trillions of  microorganisms found throughout the body, with the largest numbers in the small 
and large intestines — is unique to each individual and plays a significant role in health and disease. Current 
research suggests a complex bidirectional relationship between circadian clocks and the microbiome, which 
produces metabolites that modulate innate and adaptive immune responses (125–127). Rodents exhibit daily 
rhythms in microbiome mass that are driven by circadian patterns in feeding behavior (128, 129). In turn, nor-
mal microbiota are necessary for normal circadian gene expression in the liver (130). Therefore, circadian-me-
diated release of  microbiota-derived metabolites may directly regulate rhythmic immune-related phenotypes. 
Rhythmic release of  metabolites may also synchronize the body to the external environment, possibly extend-
ing to the entrainment of  immune cells. One specific opportunity is to elucidate the relationship among the 
microbiota, the circadian rhythm, and immune responses, with obvious applications for gastrointestinal dis-
ease. Since metabolic and immune responses are often linked, understanding the interplay among the micro-
biome, the immune system, and circadian rhythms would also be applicable in the treatment of  metabolic 
syndrome, an important risk factor for both cardiovascular and endocrine diseases (131).
Additionally, the participants encouraged applying circadian and sleep biology to topics for which such 
influences are underexplored. Leading these were the fetal origins of  adult-onset disease (94), sex-specific 
differences in various disease models, substance abuse (132, 133), crosstalk between innate and adaptive 
immune cells, and the ability of  immune cells to induce physiological changes in nonimmune cells. A recent 
study suggested that circadian gene expression in mouse lungs could be reprogrammed by depleting mice of  
neutrophils, even though these cells are relatively uncommon in the lung parenchyma (134). It is likely that 
there are other examples of  immune end-organ crosstalk that may have physiologic or medical significance.
Challenges
Circadian and sleep biology hold considerable promise for the development of  immunomodulatory 
therapies to combat disease. However, there was agreement among the Workshop participants that 
scientific, technical, and cultural challenges must be overcome if  chronotherapy is to be applicable in 
a general clinical setting.
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Scientific challenges. We are living through a great era of  molecular genetics, in which the ability to mod-
ulate the expression of  single genes is transforming the way we understand disease. The discovery of  the 
molecular circadian clock might never have occurred without genetic screens in Drosophila (7), and sleep 
research also benefits from the application of  genetics (135). Unquestionably, knockout mice and other 
genetic reagents represent important stepping-stones for examining circadian-sleep–immune connections, 
but exclusive reliance on genetic approaches in model organisms is not without caveats. While the use 
of  small molecule modulators should complement genetic approaches, caution should be exercised with 
them too. This is due to a combination of  factors, including complexity of  the immune system, multiple 
cell types and peripheral tissues involved, and genetic redundancy in the circadian clock. Thus, exclusive 
reliance on either genetic or chemical techniques to infer mechanism can be problematic. Fortunately, there 
are diverse ways, including genetic, environmental, and chemical approaches, to interfere with circadian 
and sleep research activities (136–139). Overall, the Workshop favored a philosophy of  routine orthogonal 
validation (i.e., validating conclusions using at least two technically disparate experimental approaches) to 
better understand how circadian clocks, sleep, and immunity affect each other.
Technical challenges. One important technical need for facilitating trials incorporating circadian biology 
is a quick and robust way of  determining the circadian phase of  an individual (biological time of  day versus 
external time). The reason for this is that in developed regions, nearly every individual is at risk of  desyn-
chrony due to modern-day infrastructure (i.e., artificial light, social media, irregular sleep-wake schedules, 
time zone changes, etc.). This is evident from prospective observations of  nurses whose circadian rhythms 
in body temperature were shown to be out of  phase as much as 3 days after a night shift (140). On the gene 
expression level, analyses of  human circadian transcriptomes from biopsy samples suggest that about 20% 
of  the populace is significantly out of  phase relative to the majority, perhaps reflecting the prevalence of  
shift work in developed countries (141). What this means is that any chronotherapy trial wherein an inter-
vention is pegged to a set time of  day must contend with the fact that the internal biological time of  patients 
involved can be quite different. Future attempts to translate circadian biology to the clinic will need to focus 
on ways of  defining the circadian phase of  each participant in advance so that the therapy is applied at the 
optimal time for each individual. To this end, it would be valuable to include a run-in period where sleep 
hygiene and uniform circadian entrainment are pursued as a goal before a chronotherapy intervention is 
attempted. However, Workshop participants noted that requiring a run-in period for chronotherapy trials 
could discourage future research because of  the increased cost and study complexity this practice would 
incur. Fortunately, recent work on circadian biomarkers suggests that spot analysis of  gene expression in 
blood samples can determine patients’ internal circadian time, which could potentially offset the need for 
a run-in period (142, 143). Similarly, robust and quantifiable biomarkers of  sleep debt would greatly facili-
tate translational circadian rhythm research, as sleep disturbance may mask the immunologic benefits of  a 
chronotherapy intervention.
Another technical challenge is that circadian amplitudes vary dramatically between individuals (49), 
but the significance of  this variation is not known. At the gene expression level, all circadian transcriptomes 
compiled to date represent average gene expression across a tissue sample or collection of  cells. When 
the amplitude of  clock gene expression is found to be relatively low (as occurs after shift work; ref. 144), 
it could mean that clock gene expression has been identically damped in each individual cell, or that the 
cellular clocks in the sample have fallen out of  phase with one another so that the average of  the signals 
is low. To decipher the meaning of  circadian amplitude changes, profiling of  circadian rhythms at the sin-
gle-cell level will likely be required. To generate high-quality circadian transcriptomes from mammalian 
tissue, RNA-sequencing (RNA-Seq) reads on the order of  20–40 million per sample are needed (145), but 
current single-cell sequencing technology delivers on the order of  thousands of  reads per cell. Technical 
improvements that extend the reading depth of  single-cell RNA-Seq would foster its application to circadi-
an measurements in humans and could greatly speed translational research.
Cultural challenges. In addition to posing scientific and technical challenges, chronobiology runs against 
the grain in much of  the developed world, which is designed to liberate people from natural biological 
rhythms. Many may enjoy the convenience and stimulation offered by the so-called 24-7 society. Night-
time illumination renders streets safer, and in a culture where people consider time a precious commodity, 
sleep can be construed as wasteful. Specific to the patient experience, the process of  care in hospitals is 
designed around the rapid provision of  diagnostic services and medical intervention, and thus circadian 
rhythms and sleep quality are inevitably disregarded. Nevertheless, biological sleep and consolidated circa-
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dian rhythms are essential for health, and a greater effort to communicate scientific findings to the general 
public and the medical community is urgently needed. Ultimately, societies may or may not be prepared 
to make changes in, for example, how hospitals are run or the adoption of  time-release drug preparations 
that are more expensive in the short term but confer superior medical and economic utility in the long term 
(146). Regardless of  these meta-issues, small innovations can yield significant benefits. For example, sim-
ply recording the times immunologic assays are conducted may improve the reproducibility of  preclinical 
research in some circumstances, even when circadian rhythms are not the intended focus of  study (34, 147). 
Another recommendation raised by Workshop participants was to modify preclinical toxicology studies 
such that new investigational drugs are dosed at different times of  day. This might help reduce side effects 
in phase I clinical trials, leading to a more streamlined approval process.
Conclusion
Emerging intersectional research on sleep, circadian rhythms, and immunity presents exciting opportuni-
ties for using scientific understanding to augment the immune resilience of  shift workers and other at-risk, 
but otherwise healthy, personnel, while at the same time mitigating the burden of  major inflammatory 
diseases. A better understanding of  how the immune system utilizes time as a biological variable could 
engender the development of  new immunomodulatory therapies and the timing of  administration of  thera-
pies, all of  which may help improve the efficacy of  existing drugs. A deeper understanding may also aid in 
the development of  regimens to maximize vaccine efficacy, combat infections, and optimize time of  organ 
transplant to minimize rejection. While connections to adaptive immunity and neuroinflammatory reflexes 
represent some highly opportune areas for study in the present, there are many areas of  disease physiology 
for which the insights of  circadian and sleep biology have yet to be considered. We may discover that cir-
cadian rhythms are an essential clinical element that must be factored into health and prevention efforts, as 
well as the diagnosis and therapeutics of  disease.
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